History of Innovation
Research Triangle Park (RTP) was founded in 1959 as a hub for research and innovation, anchored by the academic strengths of Duke University, NC State, and UNC-Chapel Hill. Early tenants like IBM, RTI International, and Burroughs Wellcome (now GSK) established RTP's reputation as a leader in technology within both the physical and life sciences, while government institutions like the National Institute of Environmental Health Sciences further reinforced its research focus.
This foundation of innovation and ambition laid the groundwork for an entrepreneurial ecosystem, inspiring spinouts, startups, and innovation-driven ventures within the region.
The Research Triangle has experienced distinct cycles driven by innovation, growth, and reinvestment. Early IPOs, such as SciQuest and Inspire Pharmaceuticals, set the stage for acquisitions like SpectraSite and Quintiles, which strengthened the region's biotech and technology footprint. Major exits, including Red Hat's acquisition and AskBio's $4 billion sale, fueled further momentum, attracting talent and capital.
This growth cycle continues today with the rise of companies from Pendo to Tune Therapeutics, showcasing the Triangle's ability to evolve, scale startups into major players, and reinvest resources into the next wave of entrepreneurship.
Present-Day Market
This evolution has been fueled, in part, by a broader transformation in the global startup ecosystem and the dramatic growth of venture capital as an asset class. With more venture dollars available, financing options for startups have expanded significantly, enabling founders to pursue more ambitious goals and scale their companies faster than ever before.
As the Triangle tech ecosystem evolved, so has entrepreneurship itself--attitudes, funding structures, and pathways to growth are remarkably different from 50 years ago. Much of this growth stems from the software sector, specifically from the rapid growth within SaaS, which has become almost synonymous with venture capital thanks to its low capital requirements, rapid scalability, and predictable recurring revenue models.
However, over the last decade, there has been a subtle yet meaningful shift toward venture dollars flowing into companies rooted in scientific and engineering breakthroughs addressing some of the world's most pressing challenges. Unlike the software sector, which often relies on existing platforms and rapid iterations, deeptech requires a different approach--one that demands long-term investments, significant technical expertise, and robust ecosystems of innovation.
This shift aligns more closely with the mentalities employed in the early days of venture capital, when funding was directed toward pioneering advancements in the industries of the future like semiconductors and biotechnology, exemplified by companies such as Fairchild Semiconductor and Genentech, which laid the groundwork for transformative industries that reshaped entire economies.
Capitalizing On the Opportunity Ahead
The Triangle is uniquely positioned to capitalize on this shift. With approximately $4 billion in annual federal research and development funding flowing through its universities and institutions, the region has established itself as a national leader in academic innovation. This drives cutting-edge research and sustains a steady pipeline of top-tier talent, as thousands of highly skilled graduates from the Triangle's universities enter the workforce each year.
State-level investments, such as those from NCInnovation, further bolster the region's capacity to translate research into impactful technologies, providing critical infrastructure and resources to accelerate commercialization efforts.
As venture capital increasingly reverts back to the transformative potential of science-driven startups, the Triangle's ecosystem is uniquely equipped to lead this new wave of technological advancement in areas like medical devices, life science tools, advanced materials, manufacturing, and agricultural technology.
Fully capitalizing on the opportunity ahead will require our ecosystem to align itself around building within deeptech and executing a focused strategy toward creating a generation of great technology businesses across the physical and life sciences.
After two years of investing in Triangle-based startups, we hold a strong conviction that the Triangle is uniquely positioned to build great companies in the applied sciences and believe focusing on deeptech startups will provide the largest ROI for our region in terms of both financial returns and ecosystem growth. We've also noticed a lack of coverage amplifying some of the Triangle's most interesting deeptech startups.
We believe elevating these founders and companies is important and have decided to spotlight 10 Triangle-based deeptech companies each year. In 2025, we'll be sitting down with founders, investors, and operators across the Triangle to dive deeper into the startups, institutions, and people that make our ecosystem so uniquely strong--stay tuned.
We're calling this list The Spotlight, which will highlight a recent win--an exit or event we view as a great example of local wealth creation--and call out ten noteworthy startups at a variety of stages, building across numerous industries, all based here in the Triangle. While we are active investors in this space, we are not investors in every company mentioned below; our goal is to highlight some of the best examples of companies building in areas where the Triangle is uniquely positioned to win.
Recent Win: Blue Force Technologies
Management: Scott Bledsoe, Joseph Murray
Acquirer: Anduril Industries
Anduril's acquisition of Blue Force Technologies marks a milestone for both the defense sector and North Carolina's technology ecosystem. For Anduril, a leader in advanced defense technologies, this acquisition enhances its capabilities in situational awareness and tracking solutions, solidifying its position as a provider of innovative technologies for defense and security applications.
This acquisition brings a new level of sophistication to Anduril's ability to create interoperable, real-time data solutions that enhance operational efficiency and safety.
For North Carolina, the deal underscores the state's growing role as a hub for dual-use technology. With a strong foundation in aerospace, engineering, and data analytics, the Triangle region has become a magnet for startups and established companies seeking to push the envelope in defense innovation.
The merger not only demonstrates the region's ability to attract high-impact investments, but also signals to the broader world that North Carolina is emerging as a critical player in the defense innovation space. This move highlights the growing synergy between defense, technology, and commercialization in the state--positioning it as a key player in shaping the future of defense innovation.
The acquisition is a great example of what gets us excited about local wealth creation. Anduril's growing presence in the Triangle will create new jobs and stimulate local investment. Blue Force's founders and team will reinvest their capital, both human and financial, into the local early-stage community.
Congrats to Scott, Joseph, and the Blue Force team.
The Spotlight 2024
Codetta Bio
Management: Jacques Corriveau, William Henley
Total Funding: $27.2mm
Local Investors: 2ndF
Codetta Bio develops advanced multi-omics biomarker measurement tools that allow for simultaneous analysis of DNA, RNA, and proteins from a single sample. Their integrated platform significantly reduces analysis time from two days to just two hours, enhancing efficiency and decision-making in research and clinical trials.